73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researching a new treatment option for severe blood disorders of the bone marrow

Researching a new treatment option for severe blood disorders of the bone marrow

by Anne Grimm,Leipzig UniversityCredit: CC0 Public DomainWhen people develop myelodysplastic neoplasms (MDS), the healthy maturation of blood cells is impaired. Severe forms, known as higher-ris

Researching a new treatment option for severe blood disorders of the bone marrow

by Anne Grimm,Leipzig UniversityCredit: CC0 Public DomainWhen people develop myelodysplastic neoplasms (MDS), the healthy maturation of blood cells is impaired. Severe forms, known as higher-ris
Talazoparib + enzalutamide beneficial in metastatic prostate cancer

Talazoparib + enzalutamide beneficial in metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according

Talazoparib + enzalutamide beneficial in metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according
A novel pill to treat bleeding from uterine fibroids aims for FDA approval

A novel pill to treat bleeding from uterine fibroids aims for FDA approval

by Marie McCulloughCredit: CC0 Public DomainFor millions of premenopausal women, uterine fibroids turn their monthly periods into virtual hemorrhages.A new drug called elagolix cut blood loss by half

A novel pill to treat bleeding from uterine fibroids aims for FDA approval

by Marie McCulloughCredit: CC0 Public DomainFor millions of premenopausal women, uterine fibroids turn their monthly periods into virtual hemorrhages.A new drug called elagolix cut blood loss by half
Inequities seen in cancer treatment delay in patients with SARS-CoV-2

Inequities seen in cancer treatment delay in patients with SARS-CoV-2

by Elana GotkineRace and ethnicity and area-level social determinants of health (SDOH) are associated with delayed or discontinued cancer treatment among patients with severe acute respiratory syndrom

Inequities seen in cancer treatment delay in patients with SARS-CoV-2

by Elana GotkineRace and ethnicity and area-level social determinants of health (SDOH) are associated with delayed or discontinued cancer treatment among patients with severe acute respiratory syndrom
Colorectal cancer risk remains despite modern treatment for ulcerative colitis

Colorectal cancer risk remains despite modern treatment for ulcerative colitis

byKarolinska InstitutetJonas Ludvigsson, professor in the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Sweden. Credit: Gustav MårtenssonPatients with the infl

Colorectal cancer risk remains despite modern treatment for ulcerative colitis

byKarolinska InstitutetJonas Ludvigsson, professor in the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Sweden. Credit: Gustav MårtenssonPatients with the infl
Childhood cancer deaths in the United States have declined six-fold over the last seventy years

Childhood cancer deaths in the United States have declined six-fold over the last seventy years

Childhood cancer deaths in the United States have fallen dramatically over time, as shown in the chart. It presents annual cancer death rates in children under five years old.

Childhood cancer deaths in the United States have declined six-fold over the last seventy years

Childhood cancer deaths in the United States have fallen dramatically over time, as shown in the chart. It presents annual cancer death rates in children under five years old.
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t

Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAdding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) t
B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells

B-Cell Lymphoma Treatment Options

B-Cell Lymphoma Treatment OptionsByJennifer Sabour, MSPublished on March 07, 2022Medically reviewed byDoru Paul, MDWhile B-cell lymphoma always originates in white blood cells
Why millennials should know colon cancer symptoms

Why millennials should know colon cancer symptoms

by Deb BalzerCredit: Unsplash/CC0 Public DomainMore younger adults are being diagnosed with colon cancer —also known as colorectal cancer—and at more advanced stages of the disease, says the American

Why millennials should know colon cancer symptoms

by Deb BalzerCredit: Unsplash/CC0 Public DomainMore younger adults are being diagnosed with colon cancer —also known as colorectal cancer—and at more advanced stages of the disease, says the American
Multi-center study sheds light on understudied breast cancer type

Multi-center study sheds light on understudied breast cancer type

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainA multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive bre

Multi-center study sheds light on understudied breast cancer type

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainA multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive bre
Scientists find powerhouses that fight tumours from within

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "
As cancer deaths decline, access to care remains a challenge in some US communities

As cancer deaths decline, access to care remains a challenge in some US communities

by Alex Osiadacz,Mayo ClinicCredit: Unsplash/CC0 Public DomainCancer remains the second-leading cause of death in the U.S., but the number of people dying from cancer continues to decline. In th

As cancer deaths decline, access to care remains a challenge in some US communities

by Alex Osiadacz,Mayo ClinicCredit: Unsplash/CC0 Public DomainCancer remains the second-leading cause of death in the U.S., but the number of people dying from cancer continues to decline. In th